Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery (GIP-PET)
The Effects of Glucose-dependent Insulinotrophic Peptide (GIP) and Glucagon-like Peptide 1 (GLP-1) on Splanchnic Redistribution of Blood Flow at Postprandial State and After Roux-en-Y Gastric Bypass and Sleeve
Sponsor: Lund University
A PHASE1 clinical study on Obesity and Type 2 Diabetes, this trial is completed. The trial is conducted by Lund University and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
-
Jan 2021 — Nov 2021 [monthly]
Unknown Status PHASE1
-
Dec 2018 — Jan 2021 [monthly]
Unknown Status PHASE1
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Unknown Status PHASE1
-
Jun 2017 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE1
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lund University
- Turku University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .